Janssen Search
Search results
Increasing Sustainable Access to Medicines
Increasing Sustainable Access to Medicines Janssen, as part of its commitment to Global Public Health, cultivates and helps implement innovative pricing and results-based financing models that improve access to our medicines for patients in resource ...
Avrum Spira, M.D., M.Sc.
AVRUM SPIRA, M.D., M.Sc. GLOBAL HEAD LUNG CANCER INITIATIVE AT JOHNSON & JOHNSON AND WORLD WITHOUT DISEASE ACCELERATOR Avrum “Avi” Spira, M.D., M.Sc. is the Global Head of Johnson & Johnson’s cross-sector Lung Cancer Initiative (LCI). The vision ...
Disease Interception Accelerator
DIA and Type One Diabetes Presbyopia and Cataracts Perinatal Depression Oral Cavity and Oropharyngeal /Cervical Cancer Gestational Diabetes Mellitus Chronic Obstructive Pulmonary Disease Wendy Johnson and Her Hope for Disease Interception- block Oral ...
Wayne Drevets, M.D.
WAYNE DREVETS, M.D. DISEASE AREA LEADER, NEUROPSYCHIATRY Wayne Drevets, M.D. is Stronghold Leader, Neuropsychiatry Disease Area for Neuroscience, where he leads a cross-functional team in the development of Janssen's industry-leading portfolio of ...
Celebrating Our Progress toward an Effective HIV Vaccine
Celebrating Our Progress toward an Effective HIV Vaccine Today marks an exciting milestone: the full enrollment of volunteers in the first efficacy study for Janssen’s investigational preventive HIV vaccine. The Imbokodo study is designed to help ...
Rheumatology – Treating Rheumatoid Arthritis
Rheumatology: Leveraging Expertise in Biomarkers and Co-Diagnostics to Personalize Medicine For more than a decade, Janssen has been providing patients and physicians with important therapies to treat rheumatoid arthritis (RA) and other rheumatic diseases ...
Wim Parys, M.D.
Wim Parys, M.D., obtained his medical degree from the Katholieke Universiteit Leuven, Belgium. He was in private practice for nine years before joining the Janssen Research Foundation in Beerse, Belgium, where he held several R&D positions and ...
Janssen to Highlight Innovation in Retinal Pipeline at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
Apr 21, 2023 United States Click to Access Audio Press Release Important new data on Janssen’s investigational gene therapy portfolio, including botaretigene sparoparvovec (bota-vec) and JNJ-1887, will be presented RARITAN, N.J., April 21, 2023 – The ...
Najat Khan, Ph.D.
NAJAT KHAN, Ph.D. CHIEF DATA SCIENCE OFFICER GLOBAL HEAD, STRATEGY & OPERATIONS JANSSEN R&D Najat Khan, Ph.D., is the Chief Data Science Officer and the Global Head (Vice President) of Strategy & Operations for Janssen Research & ...
Carcinogenic Exposure Meter QuickFire Challenge
Carcinogenic Exposure Meter QuickFire Challenge Janssen Research & Development, LLC and Johnson & Johnson Innovation, JLABS launched the Carcinogenic Exposure Meter QuickFire Challenge, aimed to help foster innovation that can measure the impact ...